170793-00-7

Usage

Uses

Used in Pharmaceutical Synthesis:
4-CHLORO-3-FLUOROPHENYLMAGNESIUM BROMIDE is used as a key reagent in the synthesis of pharmaceuticals for its ability to form carbon-carbon bonds efficiently. This property is essential in creating complex molecular structures required for the development of new drugs.
Used in Agrochemical Production:
In the agrochemical industry, 4-CHLORO-3-FLUOROPHENYLMAGNESIUM BROMIDE is utilized as an intermediate in the production of various agrochemicals, contributing to the synthesis of compounds that help in pest control and crop protection.
Used in Organic Chemistry Research:
4-CHLORO-3-FLUOROPHENYLMAGNESIUM BROMIDE serves as an important tool in academic and industrial research for organic chemistry, enabling chemists to explore new reaction pathways and develop innovative synthetic methods.
Used in the Creation of Advanced Materials:
This organometallic compound is also used as a precursor in the synthesis of advanced materials with unique properties, such as in the development of new polymers, materials for energy storage, and other high-tech applications.

InChI:InChI=1/C6H3ClF.BrH.Mg/c7-5-3-1-2-4-6(5)8;;/h1,3-4H;1H;/q-1;;+2/p-1

Upstream product

• 60811-18-9 2-chloro-5-bromofluorobenzene 

Downstream Products

• 917898-95-4 3-(4-bromo-phenyl)-3-(4-chloro-3-fluoro-phenyl)-2-cyano-propionic acid ethyl ester 
• 1257320-80-1 tert-butyl 5-oxo-5-(4-chloro-3-fluorophenyl)pentylcarbamate 
• 1199793-09-3 tert-butyl [2-(4-chloro-3-fluorophenyl)-1-(6-chloropyridin-3-yl)-2-hydroxy-1-methylethyl]carbamate 
• 348-60-7 4-chloro-3-fluorophenol 
• 1453851-65-4 2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl methanesulfonate 
• 1453848-20-8 1-((4-chloro-3-fluorophenyl)(oxazol-5-yl)methyl)-4-(2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one 
• 1453853-44-5 1-((4-chloro-3-fluorophenyl)(oxazol-5-yl)methyl)-4-(2-(methyl sulfonyl)pyrimidin-4-yl)pyridin-2(1H)-one 
• 1453853-42-3 1-((4-chloro-3-fluorophenyl)(oxazol-5-yl)methyl)-4-(2-(methylthio)pyrimidin-4-yl)pyridin-2(1H)-one 
• 1453853-40-1 5-(chloro(4-chloro-3-fluorophenyl)methyl)oxazole 
• 1453847-79-4 1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl)pyrimidin-2(1H)-one 
• 1453852-84-0 1-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-4-(2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)pyrimidin-2(1H)-one 
• 1453852-82-8 1-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-4-(2-(methylsulfonyl)pyrimidin-4-yl)pyrimidin-2(1H)-one 
• 1453852-80-6 1-(2-(tert-butyldimethylsilyloxy)-1-(4-chloro-3-fluorophenyl)ethyl)-4-(2-(methylthio)pyrimidin-4-yl)pyrimidin-2(1H)-one 
• 1453847-71-6 1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(5-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one 

Relevant academic research and scientific papers

CaSR antagonist

A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.